innovation that transforms
science into life
we develope high-purity peptides and verification
systems that elevate research and development
standars worldwide
VERIFIED QUALITY
peptides valided under
the highest standars
SCIENCE THAT ADVANCE
Driving research with
relieable solutions
GLOBAL TRUST
products used by
researchers worldwide
standards that out perform the market
batch verified
Each lot includes COA review and unique QR codeE
certified purity
Peptides with purity>99% verified by HPLC and LC-MSE
global distribution
Worldwide shipping with safe, discret logisticsE
quality control
Manufactured under strict standards controlled at every stageE
retatrutide 10MG
PRECISION PEPTIDE SYSTEM
Designed for advanced research protocols with maximum
precision and purity
Research use only
>99% Purity
Batch Verified
our peptides
BPC-157 + TB-500 is a dual-peptide research blend designed for advanced studies related to tissue repair signaling, extracellular matrix remodeling, inflammatory modulation, angiogenic pathways, and cellular recovery mechanisms.
This formulation combines two extensively researched regenerative peptides:
BPC-157, a synthetic peptide fragment associated with gastric pentadecapeptide research, commonly studied for its role in fibroblast activity, collagen organization, angiogenesis, tendon-ligament models, intestinal barrier integrity, and local tissue repair signaling.
TB-500, a synthetic version of a thymosin beta-4 related peptide fragment, studied for its influence on actin regulation, cell migration, tissue remodeling, wound-healing pathways, and recovery-related cellular processes.
Together, BPC-157 and TB-500 are commonly investigated as a complementary regenerative peptide system due to their potential interaction with tissue repair, mobility, inflammatory balance, and structural recovery models.
Product format: Lyophilized peptide blend
Concentration: 10 mg total
Category: Regenerative Research
Peptide system: BPC-157 + TB-500
Use: Research use only
Synthera Labs presents this compound as part of its regenerative research line, supported by global raw material sourcing, analytical documentation review, downstream processing standards, batch traceability, and QR-linked verification.
Disclaimer: This product is intended for laboratory research purposes only. Not for human consumption, diagnostic use, therapeutic use, or clinical application.
Retatrutide 10 mg is a next-generation research peptide designed as a triple receptor agonist, targeting the GLP-1, GIP, and glucagon receptor pathways involved in metabolic regulation, energy balance, appetite signaling, insulin sensitivity, and substrate utilization.
As a multi-pathway metabolic compound, Retatrutide has gained significant attention in advanced obesity, body composition, and metabolic research due to its ability to engage complementary incretin and glucagon-related mechanisms within a single molecular platform.
Synthera Labs presents Retatrutide as part of its precision peptide system, integrating global API raw material sourcing, analytical documentation review, downstream processing, batch traceability, and QR-linked verification.
Product format: Lyophilized peptide
Concentration: 10 mg
Category: Metabolic Research
Pathways: GLP-1 / GIP / Glucagon
Use: Research use only
Supplier documentation for Retatrutide raw material includes COA parameters such as purity, assay, peptide content, residual solvent data, water content, endotoxin conformity, and mass spectrum confirmation. The uploaded HHDPharma COA lists Retatrutide CAS 2381089-83-2, batch HHD20250604, purity 99.35%, assay 99.7%, peptide content 92.5%, endotoxin conformity, and mass spectrum conformity.
The supplier HPLC report also shows a main chromatographic peak at 13.989 min with an area percentage of 99.4506% at 220 nm, supporting the purity profile of the analyzed sample.
Disclaimer: This product is intended for laboratory research purposes only. Not for human consumption, diagnostic use, therapeutic use, or clinical application.
GHK-Cu 50 mg is a copper-binding research peptide complex studied for its role in skin remodeling, extracellular matrix regulation, collagen synthesis signaling, wound-healing pathways, antioxidant defense, and regenerative tissue models.
GHK-Cu is a naturally occurring tripeptide complex composed of glycyl-L-histidyl-L-lysine bound to copper, commonly investigated in aesthetic, dermatological, and regenerative research due to its interaction with biological processes related to tissue repair and structural protein regulation.
Research models have explored GHK-Cu for its potential involvement in:
collagen and elastin-associated pathways
fibroblast activity
extracellular matrix remodeling
wound-healing signaling
skin quality and tissue regeneration models
oxidative stress modulation
hair follicle and scalp-related research pathways
Synthera Labs presents GHK-Cu as part of its aesthetic and regenerative research line, supported by global raw material sourcing, analytical documentation review, downstream processing standards, batch traceability, and QR-linked verification.
Product format: Lyophilized peptide
Concentration: 50 mg
Category: Aesthetic / Regenerative Research
Peptide system: GHK-Cu
Use: Research use only
Disclaimer: This product is intended for laboratory research purposes only. Not for human consumption, diagnostic use, therapeutic use, or clinical application.